Physician profile
Robert A Aitken
NPI 1386805646
$2,920.68
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,427 · 2020: $36.27 · 2021: $31.36 · 2022: $148 · 2023: $173 · 2024: $105.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $278.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $278.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,431.32 | 2019-2023 | Amplatzer Amulet |
| Edwards Lifesciences Corporation | $177.47 | 2019-2024 | |
| Abiomed | $118.94 | 2022 | |
| Merck Sharp & Dohme LLC | $34.83 | 2019-2021 | |
| Chiesi USA, INC. | $33.02 | 2019-2020 | |
| Pacira Pharmaceuticals Incorporated | $29.13 | 2021-2022 | |
| Karl Storz Endoscopy-America | $18.94 | 2020 | |
| Silk Road Medical, INC. | $18.11 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Nonin Medical, INC. | $15.73 | 2019 | |
| Argon Medical Devices, INC. | $15.63 | 2024 | Clot Management |
| Boston Scientific Corporation | $14.02 | 2022 | |
| Medtronic, INC. | $13.54 | 2024 | Mcgrath Mac |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Aitken listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.